|
May 31
|
Shareholders Will Likely Find Sutro Biopharma, Inc.'s (NASDAQ:STRO) CEO Compensation Acceptable
|
|
May 13
|
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
|
|
May 13
|
Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for
|
|
May 13
|
The past three years for Sutro Biopharma (NASDAQ:STRO) investors has not been profitable
|
|
May 1
|
AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?
|
|
Apr 30
|
Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRĪ±ME-O1 Trial
|
|
Apr 2
|
Sutro Biopharma, Inc. (NASDAQ:STRO) Analysts Just Cut Their EPS Forecasts Substantially
|
|
Apr 2
|
Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering
|
|
Mar 27
|
Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances
|
|
Mar 25
|
Sutro Biopharma, Inc. (STRO) Q4 Earnings and Revenues Surpass Estimates
|
|
Mar 25
|
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
|
|
Mar 21
|
Here's Why Sutro Biopharma (STRO) Is a Great 'Buy the Bottom' Stock Now
|
|
Feb 28
|
Sutro Biopharma, Inc. (STRO) Surges 9.5%: Is This an Indication of Further Gains?
|
|
Dec 18
|
Sutro Biopharma, Inc.'s (NASDAQ:STRO) Share Price Boosted 48% But Its Business Prospects Need A Lift Too
|
|
Dec 4
|
Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit
|
|
Nov 27
|
Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates
|
|
Nov 13
|
Sutro Biopharma Inc (STRO) Reports Q3 2023 Financial Results and Business Updates
|
|
Nov 13
|
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
|
|
Nov 13
|
Why Sutro Biopharma (STRO) Might Surprise This Earnings Season
|
|
Aug 10
|
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Lags Revenue Estimates
|